Updated
Updated · Newsweek · Jun 18
Rheumatologist Flags 4 Early Scleroderma Signs in 300,000 Americans
Updated
Updated · Newsweek · Jun 18

Rheumatologist Flags 4 Early Scleroderma Signs in 300,000 Americans

3 articles · Updated · Newsweek · Jun 18

Summary

  • Dr. Elizabeth Volkmann said four often-overlooked symptoms—Raynaud’s phenomenon, fatigue, reflux and broader gastrointestinal issues—can point to scleroderma earlier when they appear together.
  • 300,000 Americans live with scleroderma, and about one-third have the more serious systemic form; Volkmann said the early signs are frequently dismissed because each also appears in more common conditions.
  • Gastrointestinal problems are often mistaken for IBS, while fatigue may be blamed on stress or lifestyle, delaying diagnosis for years and pushing back treatment and symptom management.
  • No cure exists, but disease-modifying therapies can target complications such as skin and pulmonary fibrosis, while research into cellular therapies is raising hopes for longer remissions.

Insights

When common symptoms hint at a rare disease, how can we ensure a faster, accurate diagnosis?
Could AI analyze health data to catch overlooked diseases like scleroderma much earlier?
What promising cellular therapies could soon offer new hope for scleroderma patients?